March 21, 2012
by admin
0 comments
The launch of Index Ventures’ new life sciences fund on March 21st is another big step in the reincarnation of the biotech investment model. As a smaller, focused fund it will carry even further the “asset-centric” strategy Index have championed. … Continue reading
March 13, 2012
by admin
2 Comments
It can take years or even decades to properly understand a pathway. But when a certain threshold is passed, new therapeutic opportunities can be revealed at an exciting rate. The apolipoprotein E (apoE) pathway has passed that threshold, and VC-backed … Continue reading